BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37793855)

  • 1. Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma.
    Wu K; Liu Z; Liang J; Zhu Y; Wang X; Li X
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma.
    Landwehr LS; Altieri B; Schreiner J; Sbiera I; Weigand I; Kroiss M; Fassnacht M; Sbiera S
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32474412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma.
    Wu K; Liu Z; Liang J; Zhang F; Zhang F; Wang Y; Lia T; Liu S; Zhu Y; Li X
    Front Endocrinol (Lausanne); 2022; 13():903824. PubMed ID: 35992138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential role of glucocorticoid receptor based on its cell type specific expression on tumor cells and infiltrating lymphocytes.
    Snijesh VP; Nimbalkar VP; Patil S; Rajarajan S; Anupama CE; Mahalakshmi S; Alexander A; Soundharya R; Ramesh R; Srinath BS; Jolly MK; Prabhu JS
    Transl Oncol; 2024 Jul; 45():101957. PubMed ID: 38643748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
    Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
    Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a tumor mutation burden-related signature combined with immune microenvironment infiltration in adrenocortical carcinoma.
    Luo Y; Chen Q; Lin J
    Math Biosci Eng; 2022 May; 19(7):7055-7075. PubMed ID: 35730296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical Carcinoma Steroid Profiles:
    Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
    Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
    Tian X; Xu W; Wang Y; Anwaier A; Wang H; Wan F; Zhu Y; Cao D; Shi G; Zhu Y; Qu Y; Zhang H; Ye D
    Oncoimmunology; 2020 Jun; 9(1):1784529. PubMed ID: 32923148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity.
    Ishikawa Y; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Tokodai K; Fujishima F; Kawanabe S; Katabami T; Ikeya A; Yamashita M; Oki Y; Nanjo H; Satoh F; Ito A; Unno M; Kamei T; Sasano H; Suzuki T
    J Steroid Biochem Mol Biol; 2024 Apr; 238():106462. PubMed ID: 38232786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Molecular Subtypes and Prognostic Characteristics of Adrenocortical Carcinoma Based on Unsupervised Clustering.
    Zhang Y; Zhang C; Li K; Deng J; Liu H; Lai G; Xie B; Zhong X
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
    Huang YG; Li D; Wang L; Su XM; Tang XB
    J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
    West DC; Kocherginsky M; Tonsing-Carter EY; Dolcen DN; Hosfield DJ; Lastra RR; Sinnwell JP; Thompson KJ; Bowie KR; Harkless RV; Skor MN; Pierce CF; Styke SC; Kim CR; de Wet L; Greene GL; Boughey JC; Goetz MP; Kalari KR; Wang L; Fleming GF; Györffy B; Conzen SD
    Clin Cancer Res; 2018 Jul; 24(14):3433-3446. PubMed ID: 29636357
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
    Lu Q; Nie R; Luo J; Wang X; You L
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    Ji D; Zhong R; Fan S
    Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenal tumors provide insight into the role of cortisol in NK cell activity.
    Greenstein AE; Habra MA; Wadekar SA; Grauer A
    Endocr Relat Cancer; 2021 Jun; 28(8):583-592. PubMed ID: 34086600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.
    Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
    Surgery; 2022 Jan; 171(1):111-118. PubMed ID: 34261605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.